Related references
Note: Only part of the references are listed.Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring
Justin Crawford et al.
EXPERIMENTAL DERMATOLOGY (2015)
Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts
Sheng Zhao et al.
JOURNAL OF CARDIOLOGY (2014)
Stimulating Myocardial Regeneration with Periostin Peptide in Large Mammals Improves Function Post-Myocardial Infarction but Increases Myocardial Fibrosis
Dennis Ladage et al.
PLOS ONE (2013)
Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts
Li Li et al.
CARDIOVASCULAR RESEARCH (2011)
Diabetic Cardiomyopathy
Shishir Murarka et al.
JOURNAL OF CARDIAC FAILURE (2010)
Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart
William E. Stansfield et al.
ANNALS OF THORACIC SURGERY (2009)
Origin of Cardiac Fibroblasts and the Role of Periostin
Paige Snider et al.
CIRCULATION RESEARCH (2009)
Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy
Dirk Westermann et al.
DIABETES (2009)
Cardiac fibroblasts: At the heart of myocardial remodeling
Karen E. Porter et al.
PHARMACOLOGY & THERAPEUTICS (2009)
The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology
Russell A. Norris et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options
Ashish Aneja et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Neonatal and adult cardiovascular pathophysiological remodeling and repair - Developmental role of periostin
Russell A. Norris et al.
CONTROL AND REGULATION OF TRANSPORT PHENOMENA IN THE CARDIAC SYSTEM (2008)
Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Simon J. Conway et al.
CURRENT GENOMICS (2008)
Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy
Hong-Yan Dai et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2008)
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling
Toru Oka et al.
CIRCULATION RESEARCH (2007)
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin
Kazuma Iekushi et al.
HYPERTENSION (2007)
Fatty acid metabolism is enhanced in type 2 diabetic hearts
AN Carley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Periostin as a novel factor responsible for ventricular dilation
N Katsuragi et al.
CIRCULATION (2004)
Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications
ZY Fang et al.
ENDOCRINE REVIEWS (2004)
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene
C Tschöpe et al.
FASEB JOURNAL (2004)
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats
P Chan et al.
JOURNAL OF HYPERTENSION (2003)
Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation
A Kruzynska-Frejtag et al.
MECHANISMS OF DEVELOPMENT (2001)
Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent
F Fiordaliso et al.
LABORATORY INVESTIGATION (2000)